Company signals · Digital Health
Sword Health
1 signal in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: Against a Talent Market Index of 111.4 (Hot) (up 5.2 month-on-month), EMEA is at easing (-4.4pts) on signal share.
Sword Health: 1 signal in the last 90 days — in line with the Digital Health median of 1 across 67 tracked companies; 0.1% of MitchelLake's EMEA signal flow.
Signals at Sword Health
MitchelLake in this thematic
More signals across Digital Health
Geographic Expansion · EMEA
Trident Digital Tech Holdings Ltd. →Unveiled five-pillar digital infrastructure strategy across Africa and Asia-Pacific with US$800M Ghana joint venture
Geographic Expansion · EMEA
Tandem Health →Sweden-based healthtech startup Tandem Health is consolidating European market dominance with AI-powered medical note-taking platform. CEO emphasizes full European focus as competitive advantage against US competitors. Company expanded from niche medical note use case to full medical assistant platform (referral notes, patient communications). Raised $50M Series A in July 2025, currently ~170 employees with UK as largest market via NHS integration.
Partnership · EMEA
Alcidion →Alcidion has secured a contract with University Hospitals Sussex NHS Foundation Trust to deliver an electronic patient record (EPR) system, expanding healthcare IT footprint in the UK.
Capital Raising · EMEA
Neko Health →Swedish health tech company raised $260 million in Series B funding in 2025. Develops advanced scanning systems combining sensors, imaging, and AI for health data collection and analysis.
Partnership · EMEA
Philips →Philips announced a 7-year strategic alliance with WellSpan Health for AI and imaging co-development across 12 hospitals in Central Pennsylvania and Northern Maryland. First joint innovation partnership between Philips and a U.S. community health system.
Product Launch · EMEA
Parexel →Parexel launched ParexelAI, a proprietary suite of human-led AI services for clinical trials, achieving 50% reduction in site selection timelines and 30% reduction in medical writing. Recent acquisition of Vitrana for pharmacovigilance.
Intelligence powered by Autonodal ↗